1. Western University of Health Sciences, Graduate School of Biomedical Science, Pomona, CA, United States;
2. Department of Psychiatry Wright University Boonshoft School of Medicine, Dayton, OH, United States;
3. Human Integrated Services Unit University of Vermont Center for Clinical & Translational Science, College of Medicine, Burlington, VT, United StatesGenetics of Alcoholism; Neuropsychiatry and Genetics; Nutritional Genetics; Pharmacogenetics
Well-known American Scientist in Psychopharmacology and Psychiatric Genetics.
Distinguished Top Professional to be featured in the Wall Street Journal.
Editor -in-Chief of Current Psychopharmacology, Addiction Psychiatry, and Theranostic and Pharmacological Sciences.
Associate Editor for Frontiers in Psychiatry and Frontiers in Public Health
Regional Editor for Current Pharmaceutical & Biotechnology. Recipient of NIH grants and has been awarded Lifetime Achievements,
Distinguished Honorary Doctors of Humane Letters;
Life-time Honorary Professor at ELTE Eötvös Loránd University, Hungary
Distinguished Honorary Professor at Adelson School of Medicine, Ariel University, Israel.
Adjunct professor at Western University, University of Vermont, Wright School of Medicine
Executive Chairman and CEO of TranspliceGen Therapeutics, Inc.
Stanford university credited him as top 2% of the World Best scientist list (2023).
The International Research Awards on Neurology and Neuro Disorders awarded him the “Best Researcher Award 2023”.
Department of Pharmacology & Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, New York, United StatesBehavioral Neuropharmacology; Neuroimaging of Addiction; Biomarkers; Chronic Effects of Methylphenidate on Skeletal Development and Brain Function
Faculty of Pharmacology, Nantes University, Paris, FranceMood disorders; anxiety disorders; bipolar disease; bipolar disorder and its treatment; psychotropics development; models of anxiety and depression
- Medical Doctor, University of TOURS, 1979
- Pharmaceutical Doctor, University of TOURS, 1970
- Degrees in Neuropsychopharmacology, Clinical pharmacology and General Pharmacology, University of PARIS (1977-1978)
- Psychiatrist 1997 (National Committee of the French Medical Board)
- Psychiatrist presently in a centre for mental handicapped adults in Montredon (near Narbonne)
- Visiting Professor University of Craiova (Romania)
- WHO expert for drug dependence (2000-2016)
- Scientific secretary of Athens ‘congress of WFSBP 2015
- Professor of Pharmacology, University of Nantes, 1985-2012
- Psychiatrist at the Nantes academic hospital till 1997
- Adjunct Professor, Department of Psychiatry, University of Edmonton (Alberta) from 1995-2006
- Head of Research: Neurobiology of anxiety and depression (University of Nantes) 1988-2009.
Center For Advanced Spinal Surgery, Tucson, AZ, United StatesOrthopedic Surgeons Diagnose; Treat Ailments affecting Muscles; Bones and Joints; Treating Sports Injuries; Degenerative Diseases; Tumors; Infections; Birth Defects
Dr. Kaiuwe Lewandrowski is an orthopedist in Tucson, Arizona and is affiliated with Carondelet St. Mary's Hospital, El Dorado Surgery Center-Tucson and Surgical Institute of Tucson. He received his medical degree from Humboldt University of Berlin- Charite Faculty of Medicine and has been in practice for more than 20 years. Dr. Kaiuwe Lewandrowski has expertise in treating spinal fusion, spinal stenosis and spondylosis, among other conditions - see all areas of expertise. Dr. Kaiuwe Lewandrowski accepts Medicare, Aetna, Humana, Cigna, Blue Cross, United Healthcare - see other insurance plans accepted.
Department of Organic Chemistry, University of Barcelona, Barcelona Science Park, Baldiri Reixac, Barcelona, SpainMedicinal and Pharmaceutical Chemistry; Organic Synthesis;; Natural Product Chemistry; Synthetic Organic Chemistry; Synthesis; High-Performance Liquid Chromatography; Chromatography; Drug Discovery; Proteins; Organic Chemistry Synthesis
1 Department of Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan;
2 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MA, USAEndometriosis; Etiopathogenesis and Diagnosis; Endometrial Cancer; Ovarian Cancer; Gynecopathology; Molecular Pathology
Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, United StatesPsychiatry; Neuroimaging; Molecular Imaging; Addiction Psychiatry; Cognitive; Memory; Consciousness; Brain; Prefrontal Cortex; Genetic Addiction Risk Severity
Professor and Chief of Psychiatry at the VA at The University of Texas Health Science Center at San Antonio.
Prof. Badgaiyan, MD, is a psychiatrist and cognitive neuroscientist. He is Chairman of the Department of Psychiatry and Behavioral Sciences at Richmond University Medical Center, and Professor of Psychiatry at Icahn School of Medicine at Mount Sinai in New York. He received formal training in psychiatry, psychology, cognitive neuroscience, molecular imaging and neuroimaging. He was awarded the prestigious BK Anand National Research Prize in India and Solomon Award of Harvard Medical School. His research is focused on the study of neural and neurochemical mechanisms that control human brain functions. He developed the single scan dynamic molecular imaging technique (SDMIT) to detect, map, and measure neurotransmitters released acutely in the human brain during task performance. This technique is now used in laboratories all over the world. Using this technique, he studies dopaminergic control of human cognition and behavior. He is also interested in learning the nature of dysregulated dopamine neurotransmission in psychiatric and neuropsychiatric conditions. His research is funded by NIMH, NINDS, VA, and various foundations. Previously he served in the faculty of Harvard Medical School, SUNY Buffalo and University of Minnesota. He has published extensively in peer-reviewed journals.
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA;
Department of Psychology, Gordon F. Derner School of Psychology, & Department of Biology, College of Arts and Sciences, Adelphi University, Garden City, NY, USAOxidative Stress; Lipid Peroxidation; Biochemistry; Natural Product Chemistry; Medicinal and Pharmaceutical Chemistry; Medicinal Plants; Antioxidant Activity; Antioxidants; Free Radicals; Reactive Oxygen Species
Department of Neuroradiology, Istituto Clinico Città di Brescia, Brescia, ItalyOzone therapy; Neuroradiology; Oxygen-ozone therapy; interventional neuroradiology; Low back pain; Disc herniation; Degenerative disc disease; Image-guided therapy; CT-guided procedures; Intradiscal injection; Spine intervention
Società Italiana per il Trattamento dell’Alcolismo e le sue Complicanze (SITAC), ASL Roma1, Sapienza University of Rome, Rome, ItalyAlcohol-Related Pathologies; Fetal Alcohol Syndrome (FAS); Pharmacological Treatment of Alcohol Dependence; Phycologic Therapy for Alcohol Dependence; Development of Community Networks; Imaging Technology for Behavioral Studies; Organic Damages by Alcohol; Genetics and Alcohol
Department of Molecular Physiology and Biological Physics, University of Virginia, USAChemistry, Biotechnology; Scientific Research; Drug Discovery; Structure-function; Spectroscopy; Reaction Mechanism; Molecular Probes; Molecular Imaging; PET and SPECT Imaging; Metabolism; Toxicology
School of Medicine, University of Missouri, Columbia, MO, United StatesMulti-Omics Studies on Phenotype Modulation in Children’s and Women’s Health; Epigenetic Mechanisms Involved in the Developmental Origin of Diseases; Epigenomics of Sleep Disorders; Epigenome Profiling in Circulating DNA in Bodily Fluids
Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, CanadaPharmacokinetics; Drug Delivery; Pharmaceutics; Pharmacology; Toxicology
Dr. Neal M. Davies received his undergraduate degree in Pharmacy from the University of Alberta in 1991. In 1996, he completed his Ph.D. in pharmaceutical sciences, specializing in pharmacokinetics, at the University of Alberta. From 1995 to 1998, he undertook postdoctoral training in pharmacology and toxicology at the University of Calgary. He then joined the University of Sydney as a lecturer in 1998. In 2002, he returned to North America to join the Washington State University’s (WSU) College of Pharmacy as an academic staff member, where he has held the positions of Director of the Pharmaceutical Sciences Graduate Program, as well as Director of Professional and Undergraduate Research and Director of Summer Undergraduate Research Fellowship program. He has been active on numerous university-wide committees, including service as a member of WSU’s Faculty Senate and Chair of the Institutional Animal Care and Use Committe. From 2011-2016 he was Dean of the Faculty of Pharmacy at the University of Manitoba. Under his direction he has been involved in several administrative and operational initiatives including: strategic planning, faculty accreditation review processes; and development of a first professional degree in Pharmacy (PharmD) program. He played key roles in faculty and graduate student recruitment and success and development of Pharmaceutical Analysis Laboratory (PAL). Throughout his career, Dr. Davies has strived to maintain the highest standard of teaching and research, and his achievements in both areas have been recognized through numerous awards and honours including several from the United States Pharmacopeia and the Canadian Society of Pharmaceutical Sciences. He has taught at the undergraduate and graduate levels, and has an ongoing and significant commitment toward graduate supervision and training. He has been at the forefront of the use of technology in the classroom, has re-engineered curricular content and maintained a high standard in student mentoring. Dr. Davies also maintains an active and highly collaborative externally-funded research program, focused on pharmacokinetics and drug delivery as well as basic and clinical pharmaceutical sciences which have attracted National Institutes of Health and Industry funds. He holds five patent applications and has disseminated his work broadly through numerous journal publications, a book and book chapters, abstracts, and invited conference presentations. He has ~8000 citations and an H-index >50. Dr. Davies has been a registered pharmacist with the Alberta College of Pharmacists since 1991. He is active in numerous professional organizations/associations, including the Canadian Society of Pharmaceutical Sciences and the American Association of Pharmaceutical Scientists, and serves as a reviewer and on the editorial board of several pharmaceutical and pharmacological science journals. Over the past decade Dr. Davies has also been heavily involved in pharmacy education research including curriculum mapping, interprofessional education, online teaching, and implementing expanded scopes of practice programs. On September 1, 2016 Dr. Davies commenced his term as Dean and Professor in the Faculty of Pharmacy & Pharmaceutical Sciences at the University of Alberta.
Coordinator of the International Head and Neck Scientific Group, Padua, ItalyHead and Neck Cancer; Neuroendocrine Neoplasms of the Head and Neck; Distant Metastases from Head and Neck Cancer
He has been honored with several distinctions from professional ENT Societies including two Presidential Citations from the American Laryngological Associationfor his contributions made to the field of laryngology and the association. He has been appointed as the International Liaison for Corresponding Fellows of the American Laryngological Association. He is also a Fellowship External Examiner in Otorhinolaryngology at the Royal College of Surgeons in Ireland.
Faculty of Sciences and Technology, University of Algarve, Faro, PortugalNanotherapy for tumor treatment; Drug delivery across biological barriers; Biopharmaceuticals; Wound healing; Tissue regeneration and cell therapy
Pedro Fonte is Assistant Professor at the Faculty of Sciences and Technology, University of Algarve, Portugal. He is also an integrated member at Center of Marine Sciences (CCMAR), University of Algarve, Portugal and collaborator researcher at the Institute for Bioengineering and Biosciences, Instituto Superior Técnico, University of Lisbon, Portugal. He graduated in Pharmaceutical Sciences in 2010 and obtained his PhD in Pharmaceutical Sciences – Nanotechnologies specialty at the Faculty of Pharmacy, University of Porto, Portugal in collaboration with the University of Copenhagen, Denmark, in 2016. He also obtained a Master of Business Administration (MBA) at the Faculty of Economics and Business Management, Lusíada University, Portugal in 2012. His area of scientific activity is on the development of new drug delivery systems by means of colloidal carriers, structural characterization of proteins entrapped into micro- and nanocarriers, lyophilization of biopharmaceuticals, targeted and controlled delivery of drugs across biological barriers, solid state characterization of pharmaceuticals and drying of pharmaceuticals and biopharmaceuticals. He is also conducting research in the regenerative medicine field, focusing in wound healing, tissue regeneration and cell therapy. In his activity he is enrolled in the up-scale of pharmaceutical products and is involved in entrepreneurship activities.
National Institute on Drug Abuse (NIDA), Bethesda, ML, United StatesBasic Brain Mechanisms Underlying Drug Addiction, Craving, and Relapse; Endocannabinoid Brain Mechanisms and Addiction; Dopamine D3 Receptor Antagonists; Glutamatergic Compounds, with Emphasis on the Metabotropic Glutamate Receptor; GABAergic Agonists, with Emphasis on the GABA-B Receptor; Slow-Onset Long-Acting Dopamine Transport Inhibitors; Drugs Acting on the Endocannabinoid Brain System
Department of Psychiatry & Institute for Public Health, Washington University in St. Louis, St. Louis, MO, United StatesEating Disorders; Addiction Psychiatry; Comorbidity; Psychopharmacology; Biological Psychiatry; Neuropsychopharmacology; Behavioral Genetics; Neuropsychiatry; Clinical Neuroscience; CNS Pharmacology
College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanChemical carcinogenesis/Mutagenesis/transformation; Oral cancer: Biology and clinical research; Pharmacology & Toxicology and Pulp/periodontal Biology; Dental Materials; Clinical endodontics; Angiogenesis, thrombosis & platelet function; Carcinogenesis & cell cycle control Oral cavity healthy & systemic diseases; Tumor cells-induced platelet activation
Medicine and Pharmacology/Physiology;
Division of Renal Diseases & Hypertension;
The George Washington University School of Medicine & Health Sciences, Washington, DC, United StatesRenal Pharmacology and Physiology; Epithelial Sodium Transport; Genetics and Pharmacogenetics of Hypertension; G Protein-Coupled Receptors
Department of Surgery, University General Hospital of Patras, Rio, GreeceGeneral Surgery; Surgical Complications; Postoperative Analgesia
Department of Internal Medicine, University of Genova, Genova, ItalyPharmacogenomics; Immunology; Vaccines; Biologics; HIV; Allergies; Atherosclerosis; Autoimmunity; Immune-mediated diseases; Immunodeficiency; Neuroendocrine-immunology
Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy).
His research has included Immunodeficiency Autoimmunity Neuro-endocrino-immunology Pharmacogenomics.
Based on this research and fellowship training he has received several awards and honors, such as:
Prize for young researchers of the study, assigned by the GILS, with the following motivation: "Standardization of a method to assess impairment by skinfold thickness skin", delivered on the occasion of the "Day VII Italian to fight Scleroderma" (Milan, 17/3 / 2001).
Award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D'Aosta, Liguria (Genoa, 06.17.2004): Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. "Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN-? and IL-4 ".
Laboratories of Biophysics and Nanotechnology, Department of Experimental Medicine (DIMES), University of Genova Medical School, Via Pastore, Genova, ItalyStructural proteomics; Nanocrystallography; Protein nanofilms; Protein Langmuir-Blodgett multilayers; Synchrotron Radiation
Faculty of Pharmacy, Universidad de Alcalá, Alcala de Henares, SpainSolubility; Dissolution; Drug Formulation; Formulation Development of Pharmaceuticals; Pharmaceutical Formulation; Pharmaceutics and Pharmaceutical Technology; Pharmaceutical Development; Drug Formulation Development; Calorimetry; DSC
Universidad de Sevilla, Sevilla, SpainPharmaceutical Analysis; Pharmaceutical Development; Pharmaceutics and Pharmaceutical Technology; Drug Formulation; Formulation Development of Pharmaceuticals; Medicinal and Pharmaceutical Chemistry; Nanoparticle Synthesis; Scanning Electron Microscopy
American Physical Society, College Park, Maryland, NA, United StatesBioavailability; Biochemistry; Cell and Body Thermodynamics; Metabolism
Department of Advanced Medical and Surgical Sciences, Università degli Studi della Campania Luigi Vanvitelli, Naples, ItalyHeart Failure; Atrial Fibrillation; Echocardiography; Electrocardiography; Clinical Cardiology; Chronic Heart Failure; Cardiac Function; Myocardial Infarction; Hypertension; Cardiovascular Medicine
Dr. Sardu is an Associate Professor at the Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy. He authored/co-authored 155 publications and 4739 citations with an h-index of 41 (Scopus, December 2023). His research interests focus on heart failure, atrial fibrillation, echocardiography, electrocardiography, clinical cardiology, chronic heart failure, cardiac function, myocardial infarction, hypertension, and cardiovascular medicine.
A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, RussiaOxidative Stress; Antioxidants; Reactive Oxygen Species; Neurodegeneration; Neurodegenerative Diseases; Cell Culture; Neuroprotection; Neurological Diseases; Stem Cells; Neurobiology; Extracellular Vesicles
Cardiovascular Translational Research Center, Department of Cell Biology and Anatomy SmartState Endowed Chair in Biofabrication, University of South Carolina, Columbia, United StatesVascular smooth muscle; Endothelium; Hypertension; Vasculogenic sexual dysfunction (male and female)
Professor, Biomedical Engineerin, 2021-Present
Professor and Chairperson, Department of Physiology Augusta University, 1999-2020
Professor (Assistant to Full), University of Michigan, 1979-99
Research Associate, Universitaire Instelling Antwerpen, 1978-79
Postdoctoral Fellow, University of Michigan, 1976-78
University of Iowa, Ph.D. (Anatomy), 1973-76
Southern Illinois University, M.S. (Physiology), 1971-73
Southern Illinois University, B.A. (Physiology), 1967-71
Department of Applied Clinical Psychology, The Chicago School of Professional Psychology, Los Angeles, CA, United StatesDevelopmental & Behavioral Psychology; Lifespan Growth, Plasticity, & Stability; Cross-Cultural Perspectives on Epigenetics, Genotype, & Phenotype behavior
Department of Psychiatry, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Republic of KoreaAddiction; Neuromodulation; Neuroimaging
EPIC, Clearwater, FL, United States;
Life University, Marietta, GA, United States;
Sherman College of Chiropractic, Spartanburg, SC, United StatesAdvancing Diagnostic Technologies for Assessing Cranial Neurovascular Health; Spinal Cord Neurotransmission; Spinal Joint Biomechanics
Tulane University School of Medicine, New Orleans, LA, United StatesAnxiety Dissociative and Somatoform Disorders; Anxiety Phobic Disorders; Attention Deficit Disorder (ADD); Bipolar Disorder; Depressive Disorders; Post Traumatic Stress Disorder (PTSD); Schizophrenia
